GAVISCON ADVANCE

500mg/100m MG/5ml Oral Suspension

Reckitt Benckiser Ireland LtdPA0979/011/001

Main Information

Trade NameGAVISCON ADVANCE
Active SubstancesSODIUM ALGINATE
POTASSIUM HYDROGEN CARBONATE
Strength500mg/100m MG/5ml
Dosage FormOral Suspension
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/011/001

Group Information

ATC CodeA02BX OTHER DRUGS FOR TREATMENT OF PEPTIC ULCER

Status

Authorised/WithdrawnAuthorised
Licence Issued14/08/1998
Supply StatusSupply through pharmacies only
Dispensing StatusProduct not subject to medical prescription
Marketing StatusMarketed
Promotion StatusPromotion to the general public
Conditions of Licence

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.